期刊文献+

HPLC法测定血浆中别嘌呤醇及氧别嘌醇的浓度

Determination the Concentration of Allopurinol and Its Metabolite-oxypurinol in Human Plasma by HPLC
下载PDF
导出
摘要 目的:建立人血浆中别嘌呤醇及其代谢产物氧别嘌醇的高效液相色谱测定方法。方法:色谱柱为Hypersil BDS C_(18)柱(250mm×4.6mm,5μm),流动相为50mmol·L^(-1)KH_2PO_4(pH 4.63)-甲醇(97:3),流速1ml·min^(-1),柱温30℃,紫外检测波长254nm。以阿昔洛韦为内标,血浆样品用高氯酸沉淀蛋白后分析。结果:别嘌呤醇在0.02~5μg·ml^(-1)范围内线性关系良好(r=0.999 2),提取回收率为76.4%~81.4%,方法回收率为98.7%~112.7%;氧别嘌醇在0.02~8μg·ml^(-1)范围内线性关系良好(r=0.999 6),提取回收率为76.3%~80.2%,方法回收率为97.2%~100.2%。结论:本法操作简便、灵敏、准确。 Objective : To develop a method for the determination of the concentration of aUopurinol and its metabolite-oxypurinol in human Plasma by HPLC. Method: The Hypersil BDS C18 column(250mm ×4.6mm, 5μm) was used at 30℃. The mobile phase was 50 mmol · L^-1 phosphate buffer solution ( pH 4.63 ) -methanol (97:3 ) , and the flow rate was 1.0 ml · min^-1. The detecting wavelength was 254nm. Acyclovir was used as internal standard. The samples were deposited by perchloric acid and then injected. Result: The linear range of allopurinol was 0.02-5 μg · ml^ -1 ( r = 0.999 2). The extraction recovery of allopurinol was 76.4% -81.4% and the method recovery was 98.7% -112.7%. The linear range of oxypurinal was 0.02-8μg · ml^ - 1 ( r = 0. 999 6 ). The extraction recovery of oxypurinol was 76.3% -80.2% and the method recovery was 97.2% -100.2%. Conclusion: The method was simple, sensitive and accurate.
出处 《中国药师》 CAS 2009年第8期1033-1034,共2页 China Pharmacist
关键词 别嘌呤醇 氧别嘌醇 血浆浓度 高效液相色谱法 Allopurinol Oxypurinol Concentration in plasma HPLC
  • 相关文献

参考文献5

  • 1胡哲益,余奇,王黎青,郭歆,叶樱,程泽能.别嘌醇缓释片人体药物动力学与生物等效性研究[J].中南药学,2005,3(1):15-18. 被引量:2
  • 2邱峰,何海霞,朱深银,周远大.别嘌醇片的生物等效性研究[J].重庆医科大学学报,2002,27(4):410-412. 被引量:2
  • 3Tada H, Fujisaki A, hoh K, et al, Facile and rapid high-performance liquid chromatography method for simultaneous determination of allopurinol and oxypurinol in human serum [J].Clin Pharm Ther,2003, 28 ( 3 ) : 229 -234.
  • 4Barthel W, Huller G, Haustein KO, et al. Bioequivalence of allopurinol-containing tablet preparations [ J]. lnt J Clin Pharmacol Ther , 1999,37 (3) : 148-152.
  • 5Guerra P, Frias J, Ruiz B, et al. Bioequivalence of allopurinol and its metabolite oxypurinol in two tablet formulations[ J]. Clin Pharm Ther, 2001,26(2) :113-119.

二级参考文献6

  • 1中国药典委员会.药物制剂人体生物利用度和生物等效性试验指导原则(中国药典,2000版二部)[M].北京:化学工业出版社,,2000.附录XI X B.
  • 2[3]Tada H, Fujisaki A, Itoh K, etal. Facile and rapid high-performance liquid chromatography method for simultaneous determination of allopurinol and oxypurinol in human serum [J].ClinPharm Ther, 2003, 28 (3): 229
  • 3[4]Barthel W, Hüller G, Haustein KO, et al. Bioequivalence of allopurinol-containing tablet preparations [J]. Iht J Clin Pharmacol Ther, 1999, 37 (3): 148
  • 4[5]Guerra P, Frias J, Ruiz B, et al. Bioequivalence of allopurinol and its metabolite oxipurinol in two tablet formulations [J].ClinPharmTher, 2001, 26 (2): 113
  • 5邱峰,何海霞,朱深银,周远大.别嘌醇片的生物等效性研究[J].重庆医科大学学报,2002,27(4):410-412. 被引量:2
  • 6覃珍,陈超.别嘌醇研究的新进展[J].中国药理学通报,2003,19(11):1220-1222. 被引量:13

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部